A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

NCT03609294 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetes

Interventions

DRUG: Treatment A (Fimasartan, Linagliptin)
DRUG: Treatment B (Fimasartan/Linagliptin)

Sponsor

Boryung Pharmaceutical Co., Ltd